<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0270">
 <label>54</label>
 <element-citation publication-type="journal" id="rf0260">
  <person-group person-group-type="author">
   <name>
    <surname>Zhang</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Z.</given-names>
   </name>
  </person-group>
  <article-title>The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China</article-title>
  <source>Clin. Immunol.</source>
  <volume>214</volume>
  <year>2020</year>
  <fpage>108393</fpage>
  <comment>May 1</comment>
  <pub-id pub-id-type="pmid">32222466</pub-id>
 </element-citation>
</ref>
